Arrowhead Pharmaceuticals, Inc. (ARWR)
USD 9.99
(-2.54%)
USD 9.99
(-2.54%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -205 Million USD | -14.84% |
| 2022 | -178.5 Million USD | -19.77% |
| 2021 | -149.03 Million USD | -59.98% |
| 2020 | -93.15 Million USD | -252.24% |
| 2019 | 61.19 Million USD | 209.39% |
| 2018 | -55.93 Million USD | -51.2% |
| 2017 | -36.99 Million USD | 54.74% |
| 2016 | -81.74 Million USD | 14.83% |
| 2015 | -95.97 Million USD | -80.14% |
| 2014 | -53.27 Million USD | -116.66% |
| 2013 | -24.58 Million USD | -16.6% |
| 2012 | -21.08 Million USD | -114.53% |
| 2011 | -9.83 Million USD | -11.68% |
| 2010 | -8.8 Million USD | 55.38% |
| 2009 | -19.72 Million USD | 43.64% |
| 2008 | -35 Million USD | 7.76% |
| 2007 | -37.94 Million USD | -78.66% |
| 2006 | -21.24 Million USD | -126.86% |
| 2005 | -9.36 Million USD | -238.14% |
| 2004 | -2.76 Million USD | -2831.96% |
| 2003 | -94.43 Thousand USD | 93.33% |
| 2002 | -1.41 Million USD | -1232.72% |
| 2001 | -106.26 Thousand USD | 2.72% |
| 2000 | -109.23 Thousand USD | -94.31% |
| 1999 | -56.21 Thousand USD | -32.91% |
| 1998 | -42.29 Thousand USD | 73.33% |
| 1997 | -158.61 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -176.14 Million USD | -39.58% |
| 2024 Q1 | -136.54 Million USD | -26.05% |
| 2024 Q2 | -126.19 Million USD | 7.58% |
| 2023 Q1 | -42.13 Million USD | 49.74% |
| 2023 Q4 | -108.33 Million USD | -5.48% |
| 2023 Q2 | 48.16 Million USD | 214.31% |
| 2023 Q3 | -102.7 Million USD | -313.23% |
| 2023 FY | -205 Million USD | -14.84% |
| 2022 Q3 | -72.9 Million USD | -275.46% |
| 2022 Q4 | -83.83 Million USD | -14.98% |
| 2022 Q1 | -63.32 Million USD | 2.41% |
| 2022 Q2 | 41.55 Million USD | 165.62% |
| 2022 FY | -178.5 Million USD | -19.77% |
| 2021 Q4 | -64.88 Million USD | -103.6% |
| 2021 Q1 | -24.05 Million USD | 52.01% |
| 2021 FY | -149.03 Million USD | -59.98% |
| 2021 Q2 | -28.23 Million USD | -17.37% |
| 2021 Q3 | -31.86 Million USD | -12.88% |
| 2020 Q1 | -4.85 Million USD | -150.36% |
| 2020 Q3 | -15.94 Million USD | 28.3% |
| 2020 FY | -93.15 Million USD | -252.24% |
| 2020 Q4 | -50.11 Million USD | -214.31% |
| 2020 Q2 | -22.24 Million USD | -358.22% |
| 2019 Q1 | 10.94 Million USD | 198.0% |
| 2019 Q3 | 18.59 Million USD | -15.51% |
| 2019 FY | 61.19 Million USD | 209.39% |
| 2019 Q2 | 22.01 Million USD | 101.08% |
| 2019 Q4 | 9.63 Million USD | -48.17% |
| 2018 Q1 | -13.81 Million USD | -34.76% |
| 2018 FY | -55.93 Million USD | -51.2% |
| 2018 Q3 | -15.91 Million USD | -5.89% |
| 2018 Q4 | -11.16 Million USD | 29.84% |
| 2018 Q2 | -15.03 Million USD | -8.84% |
| 2017 Q3 | -5.71 Million USD | 6.78% |
| 2017 Q1 | -14.9 Million USD | 31.63% |
| 2017 FY | -36.99 Million USD | 54.74% |
| 2017 Q4 | -10.25 Million USD | -79.38% |
| 2017 Q2 | -6.12 Million USD | 58.87% |
| 2016 Q2 | -21.26 Million USD | -9.95% |
| 2016 Q4 | -21.79 Million USD | -12.69% |
| 2016 Q1 | -19.34 Million USD | 23.34% |
| 2016 FY | -81.74 Million USD | 14.83% |
| 2016 Q3 | -19.34 Million USD | 9.04% |
| 2015 Q2 | -29.63 Million USD | -17.99% |
| 2015 FY | -95.97 Million USD | -80.14% |
| 2015 Q1 | -25.11 Million USD | -12.35% |
| 2015 Q3 | -15.99 Million USD | 46.03% |
| 2015 Q4 | -25.22 Million USD | -57.75% |
| 2014 Q1 | -7 Million USD | 12.37% |
| 2014 Q3 | -12.7 Million USD | -13.27% |
| 2014 Q4 | -22.35 Million USD | -76.02% |
| 2014 FY | -53.27 Million USD | -116.66% |
| 2014 Q2 | -11.21 Million USD | -59.96% |
| 2013 Q1 | -4.81 Million USD | 10.57% |
| 2013 Q2 | -5.39 Million USD | -12.06% |
| 2013 Q3 | -6.38 Million USD | -18.54% |
| 2013 Q4 | -7.99 Million USD | -25.18% |
| 2013 FY | -24.58 Million USD | -16.6% |
| 2012 FY | -21.08 Million USD | -114.53% |
| 2012 Q3 | -6.8 Million USD | -39.73% |
| 2012 Q1 | -4.03 Million USD | -38.67% |
| 2012 Q2 | -4.86 Million USD | -20.54% |
| 2012 Q4 | -5.37 Million USD | 20.94% |
| 2011 FY | -9.83 Million USD | -11.68% |
| 2011 Q4 | -2.91 Million USD | -64.54% |
| 2011 Q3 | -1.77 Million USD | 2.29% |
| 2011 Q2 | -1.81 Million USD | -79.49% |
| 2011 Q1 | -1 Million USD | 57.02% |
| 2010 Q4 | -2.34 Million USD | -8.51% |
| 2010 FY | -8.8 Million USD | 55.38% |
| 2010 Q3 | -2.16 Million USD | -1.63% |
| 2010 Q2 | -2.12 Million USD | 1.42% |
| 2010 Q1 | -2.16 Million USD | 38.52% |
| 2009 Q4 | -3.51 Million USD | -51.21% |
| 2009 FY | -19.72 Million USD | 43.64% |
| 2009 Q1 | -8.67 Million USD | 24.95% |
| 2009 Q2 | -5.21 Million USD | 39.87% |
| 2009 Q3 | -2.32 Million USD | 55.45% |
| 2008 FY | -35 Million USD | 7.76% |
| 2008 Q4 | -11.55 Million USD | -16.8% |
| 2008 Q3 | -9.89 Million USD | -39.93% |
| 2008 Q1 | -6.88 Million USD | 40.86% |
| 2008 Q2 | -7.07 Million USD | -2.72% |
| 2007 FY | -37.94 Million USD | -78.66% |
| 2007 Q2 | -8.43 Million USD | -88.58% |
| 2007 Q1 | -4.47 Million USD | 48.93% |
| 2007 Q3 | -13.39 Million USD | -58.8% |
| 2007 Q4 | -11.64 Million USD | 13.1% |
| 2006 FY | -21.24 Million USD | -126.86% |
| 2006 Q1 | -4.05 Million USD | -96.64% |
| 2006 Q2 | -3.94 Million USD | 2.65% |
| 2006 Q3 | -4.48 Million USD | -13.63% |
| 2006 Q4 | -8.75 Million USD | -95.4% |
| 2005 Q3 | -3.35 Million USD | -66.21% |
| 2005 Q4 | -2.06 Million USD | 38.59% |
| 2005 Q1 | -1.96 Million USD | -31.03% |
| 2005 Q2 | -2.01 Million USD | -2.86% |
| 2005 FY | -9.36 Million USD | -238.14% |
| 2004 Q4 | -1.49 Million USD | -151.35% |
| 2004 Q3 | -596.01 Thousand USD | -53.24% |
| 2004 Q1 | -142.52 Thousand USD | -709.6% |
| 2004 Q2 | -388.93 Thousand USD | -172.9% |
| 2004 FY | -2.76 Million USD | -2831.96% |
| 2003 FY | -94.43 Thousand USD | 93.33% |
| 2003 Q4 | -17.6 Thousand USD | -16.58% |
| 2003 Q3 | -15.1 Thousand USD | 48.76% |
| 2003 Q2 | -29.46 Thousand USD | 8.66% |
| 2003 Q1 | -32.26 Thousand USD | 97.55% |
| 2002 Q4 | -1.31 Million USD | -2599.29% |
| 2002 FY | -1.41 Million USD | -1232.72% |
| 2002 Q1 | -25.74 Thousand USD | 13.79% |
| 2002 Q2 | -22.42 Thousand USD | 12.89% |
| 2002 Q3 | -48.87 Thousand USD | -117.91% |
| 2001 Q3 | -15.51 Thousand USD | 39.21% |
| 2001 FY | -106.26 Thousand USD | 2.72% |
| 2001 Q2 | -25.52 Thousand USD | 27.79% |
| 2001 Q1 | -35.35 Thousand USD | -27.84% |
| 2001 Q4 | -29.86 Thousand USD | -92.44% |
| 2000 Q2 | -25.49 Thousand USD | 22.54% |
| 2000 Q1 | -32.91 Thousand USD | -229.15% |
| 2000 FY | -109.23 Thousand USD | -94.31% |
| 2000 Q3 | -23.16 Thousand USD | 9.13% |
| 2000 Q4 | -27.65 Thousand USD | -19.37% |
| 1999 FY | -56.21 Thousand USD | -32.91% |
| 1999 Q2 | -10 Thousand USD | 50.0% |
| 1999 Q4 | -10 Thousand USD | 95.45% |
| 1999 Q3 | -220 Thousand USD | -2100.0% |
| 1999 Q1 | -20 Thousand USD | 0.0% |
| 1998 Q4 | -20 Thousand USD | -100.0% |
| 1998 Q3 | -10 Thousand USD | 0.0% |
| 1998 FY | -42.29 Thousand USD | 73.33% |
| 1998 Q2 | -10 Thousand USD | 0.0% |
| 1997 FY | -158.61 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -46.25 Million USD | -343.19% |
| Jaguar Health, Inc. | -34.29 Million USD | -497.83% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -20.631% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -261.18% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 27.349% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 1816.647% |
| ContextLogic Inc. | -328 Million USD | 37.499% |
| MiMedx Group, Inc. | 37.11 Million USD | 652.328% |
| MEI Pharma, Inc. | 14.54 Million USD | 1509.724% |
| AlloVir, Inc. | -181.33 Million USD | -13.054% |
| Novavax, Inc. | -566.51 Million USD | 63.813% |
| Aptorum Group Limited | -10.52 Million USD | -1848.072% |
| Ardelyx, Inc. | -63.27 Million USD | -223.981% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -7349.674% |
| Vaxcyte, Inc. | -468.04 Million USD | 56.2% |
| Precigen, Inc. | -88.92 Million USD | -130.539% |
| Pharming Group N.V. | -4.87 Million USD | -4101.253% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -22.527% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -588.943% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -900.449% |
| Avidity Biosciences, Inc. | -235.59 Million USD | 12.987% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -955.704% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -743.4% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -743.4% |
| Bicycle Therapeutics plc | -189.94 Million USD | -7.926% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 25.183% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -599.546% |
| Acelyrin, Inc. | -422.06 Million USD | 51.429% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -441.345% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -453.103% |
| Senti Biosciences, Inc. | -92.72 Million USD | -121.081% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -78.615% |
| AbCellera Biologics Inc. | -237.2 Million USD | 13.577% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -498.249% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -19.338% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -6383.302% |
| Chimerix, Inc. | -93.06 Million USD | -120.278% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -520.823% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -1068.835% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -354.779% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -304.399% |
| Elevation Oncology, Inc. | -45.44 Million USD | -351.099% |
| Alkermes plc | 414.12 Million USD | 149.503% |
| Fortress Biotech, Inc. | -142.34 Million USD | -44.021% |
| Fortress Biotech, Inc. | -142.34 Million USD | -44.021% |
| Agenus Inc. | -159.54 Million USD | -28.488% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -109.841% |
| Dyadic International, Inc. | -8.22 Million USD | -2390.99% |
| ImmuCell Corporation | -5.74 Million USD | -3466.444% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -17098.154% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -52.498% |
| Lantern Pharma Inc. | -17.87 Million USD | -1046.699% |
| Immix Biopharma, Inc. | -16.14 Million USD | -1170.061% |
| Incyte Corporation | 620.52 Million USD | 133.037% |
| IO Biotech, Inc. | -91.44 Million USD | -124.186% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -180.905% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -920.429% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -285.876% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -58.931% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2311.505% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -144.3% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 46.122% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 59.35% |
| NextCure, Inc. | -67.63 Million USD | -203.092% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -1840.755% |
| Onconetix, Inc. | -36.03 Million USD | -468.903% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -391.447% |
| Opthea Limited | -191.84 Million USD | -6.859% |
| PDS Biotechnology Corporation | -43.04 Million USD | -376.248% |
| PureTech Health plc | -146.19 Million USD | -40.221% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -149.406% |
| Seer, Inc. | -103.46 Million USD | -98.14% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -1589686.381% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -725.157% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -5100.393% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -600.67% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -201.491% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -365.808% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -47.451% |
| ChromaDex Corporation | -5.59 Million USD | -3561.404% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -2871.905% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -76.636% |
| CRISPR Therapeutics AG | -222.53 Million USD | 7.88% |
| Precision BioSciences, Inc. | -43.73 Million USD | -368.726% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -7.606% |
| Innoviva, Inc. | 176.7 Million USD | 216.011% |
| Summit Therapeutics Inc. | -89.73 Million USD | -128.45% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -211.747% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -184.99% |
| ESSA Pharma Inc. | -32.13 Million USD | -537.958% |
| GlycoMimetics, Inc. | -39.27 Million USD | -421.962% |
| GT Biopharma, Inc. | -13.57 Million USD | -1410.032% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | 6.486% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 336.145% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -298.016% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -1962.883% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 21.05% |
| Aptose Biosciences Inc. | -52.35 Million USD | -291.554% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -1321.574% |
| Soligenix, Inc. | -7.69 Million USD | -2563.076% |
| Century Therapeutics, Inc. | -146.54 Million USD | -39.889% |
| Kura Oncology, Inc. | -165.8 Million USD | -23.641% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -119.352% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -2364.263% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -8160.75% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -3061.659% |
| Autolus Therapeutics plc | -195.02 Million USD | -5.114% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -142.156% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -178.301% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -869.965% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | 9.705% |
| GRI Bio, Inc. | -11.38 Million USD | -1700.316% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -4439.746% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -56.26% |
| IGM Biosciences, Inc. | -263.46 Million USD | 22.189% |
| INmune Bio, Inc. | -29.74 Million USD | -589.291% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -85.329% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -438.412% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1182.917% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -1199.881% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -235.53% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -90.661% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 25.726% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -0.887% |
| Verastem, Inc. | -92.08 Million USD | -122.625% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -334.925% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -11.326% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -73.173% |
| Histogen Inc. | -10.64 Million USD | -1826.167% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -1224.99% |
| Surrozen, Inc. | -45.78 Million USD | -347.798% |
| Organovo Holdings, Inc. | -15.08 Million USD | -1258.889% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -3927.357% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -245.811% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -299.661% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -710.926% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -2585.788% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -19.686% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -323.139% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -162.134% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -1246.857% |
| Apollomics, Inc. | -54.83 Million USD | -273.859% |
| Amarin Corporation plc | -67.58 Million USD | -203.311% |
| Mesoblast Limited | -58.79 Million USD | -248.678% |
| Turnstone Biologics Corp. | -59.03 Million USD | -247.273% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -23.846% |
| Synaptogenix, Inc. | -8.31 Million USD | -2365.788% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -1305.471% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -123.579% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4178.482% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -2221.329% |
| Exelixis, Inc. | 170.88 Million USD | 219.965% |
| Better Therapeutics, Inc. | -38.26 Million USD | -435.785% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -32.206% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 60.357% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1636.266% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -2449.172% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -583.499% |
| Gritstone bio, Inc. | -154.63 Million USD | -32.572% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -197.704% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -1097.228% |
| Avid Bioservices, Inc. | -18.67 Million USD | -997.559% |
| Insmed Incorporated | -709.62 Million USD | 71.111% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -1206.595% |
| MediWound Ltd. | -15.29 Million USD | -1240.759% |
| OmniAb, Inc. | -69.41 Million USD | -195.311% |
| Alector, Inc. | -151.74 Million USD | -35.101% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -89.847% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -293.116% |
| Zai Lab Limited | -366.57 Million USD | 44.076% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 35.285% |
| Aura Biosciences, Inc. | -84.99 Million USD | -141.204% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 16.496% |
| Immunic, Inc. | -99.22 Million USD | -106.607% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -43.2% |
| Veracyte, Inc. | -85.79 Million USD | -138.944% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 27.257% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1342.66% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -2876.242% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -990.865% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 135.432% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -705.414% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 628.328% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1093.564% |
| Galecto, Inc. | -39.9 Million USD | -413.725% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -387.242% |
| Fortrea Holdings Inc. | 63.1 Million USD | 424.884% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -45.966% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -609.89% |
| XBiotech Inc. | -37.51 Million USD | -446.526% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -197.704% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -205.426% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -89.982% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -698.543% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -284.677% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 63.985% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -161.176% |
| Vaxxinity, Inc. | -58.28 Million USD | -251.723% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -97.67% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -821.228% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -137.227% |
| NexImmune, Inc. | -29.19 Million USD | -602.242% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -3547.637% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -1305.917% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 105.065% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -705.224% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1649.929% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -61.34% |
| Ainos, Inc. | -13.2 Million USD | -1452.293% |
| Pluri Inc. | -22.15 Million USD | -825.183% |
| Prothena Corporation plc | -191.03 Million USD | -7.311% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -48.511% |
| Celularity Inc. | -192.28 Million USD | -6.613% |
| Rallybio Corporation | -78.93 Million USD | -159.72% |
| Cue Biopharma, Inc. | -52.14 Million USD | -293.108% |
| MeiraGTx Holdings plc | -137.06 Million USD | -49.57% |
| Omeros Corporation | -164.53 Million USD | -24.599% |
| Humacyte, Inc. | -100.04 Million USD | -104.906% |
| Immunocore Holdings plc | -59.64 Million USD | -243.681% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -1004.596% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -737.324% |
| Blueprint Medicines Corporation | -486.27 Million USD | 57.843% |
| CalciMedica, Inc. | -21.87 Million USD | -837.152% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -174.581% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -55.913% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -19.678% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 37.289% |
| Pulmatrix, Inc. | -14.74 Million USD | -1290.787% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -473.512% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -130.687% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 60.216% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -203.477% |
| Cytokinetics, Incorporated | -496.2 Million USD | 58.686% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -495.607% |
| Nutriband Inc. | -4.87 Million USD | -4107.823% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -370.048% |
| Vor Biopharma Inc. | -126.03 Million USD | -62.654% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 104.833% |
| Evogene Ltd. | -26.39 Million USD | -676.788% |
| ProKidney Corp. | -151.52 Million USD | -35.295% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -217.66% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -2565.049% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 66.248% |
| CorMedix Inc. | -48.95 Million USD | -318.732% |
| BioLineRx Ltd. | -49.69 Million USD | -312.529% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -79.554% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -438.459% |
| Atai Life Sciences N.V. | -125.47 Million USD | -63.386% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -151.107% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -151.817% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 17.666% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -566.89% |
| MediciNova, Inc. | -9.9 Million USD | -1970.672% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -62.22% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -2730.558% |
| GeoVax Labs, Inc. | -26.74 Million USD | -666.565% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | 11.57% |
| Biomea Fusion, Inc. | -126.13 Million USD | -62.526% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 41.328% |
| Mereo BioPharma Group plc | -28.41 Million USD | -621.432% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -7.281% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | 10.851% |
| Absci Corporation | -115.51 Million USD | -77.468% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -643.111% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -81.631% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | 15.345% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -713.629% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | 1.439% |
| Allakos Inc. | -196.05 Million USD | -4.563% |
| Imunon, Inc. | -21.03 Million USD | -874.787% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -85.247% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 291.087% |
| BioAtla, Inc. | -129.68 Million USD | -58.074% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1636.266% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -1193.959% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 37.449% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -390.929% |
| XOMA Corporation | -41.84 Million USD | -389.873% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -94.8% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -68.733% |
| aTyr Pharma, Inc. | -54.91 Million USD | -273.281% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -134.484% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -18.587% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 19.433% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -855.008% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -2396.142% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1119.814% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -2318132.552% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 160.728% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -3037.455% |
| UroGen Pharma Ltd. | -65.53 Million USD | -212.808% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -129.622% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -2722.548% |
| Orgenesis Inc. | -53.63 Million USD | -282.21% |
| Entera Bio Ltd. | -8.89 Million USD | -2205.725% |
| GH Research PLC | -41.22 Million USD | -397.312% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -697.425% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -146.833% |
| Xencor, Inc. | -138.63 Million USD | -47.867% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -3877.082% |
| Replimune Group, Inc. | -234.77 Million USD | 12.681% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -853.892% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -1369.338% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -3037.455% |
| Portage Biotech Inc. | -18.25 Million USD | -1023.114% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -2730.558% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -95.313% |
| OncoCyte Corporation | -25.13 Million USD | -715.571% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1713.398% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1689.307% |
| Purple Biotech Ltd. | 22.27 Million USD | 1020.489% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -2628.994% |
| scPharmaceuticals Inc. | -55.39 Million USD | -270.066% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -984.799% |
| HilleVax, Inc. | -133.34 Million USD | -53.738% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -1601.403% |
| Tharimmune, Inc. | -9.45 Million USD | -2068.136% |
| Genprex, Inc. | -31.07 Million USD | -559.689% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -8.931% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -553.351% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -26697.647% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -3663.632% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1301522.314% |
| Savara Inc. | -60 Million USD | -241.63% |
| Curis, Inc. | -48.33 Million USD | -324.154% |
| Daré Bioscience, Inc. | -30.83 Million USD | -564.73% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -3829.289% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -2717.122% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -652.301% |
| BeiGene, Ltd. | -1.2 Billion USD | 83.026% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -928.13% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 57.921% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -118.898% |
| Erasca, Inc. | -141.52 Million USD | -44.852% |
| bluebird bio, Inc. | -244.26 Million USD | 16.073% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -4428.455% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 205.431% |
| DBV Technologies S.A. | -76.43 Million USD | -168.215% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -4428.455% |
| Moderna, Inc. | -4.23 Billion USD | 95.164% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -381.124% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -3123.302% |
| Molecular Templates, Inc. | -10.46 Million USD | -1858.743% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -204.895% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 45.586% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -43.047% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -294.288% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -32.651% |
| Cogent Biosciences, Inc. | -208.13 Million USD | 1.503% |
| MacroGenics, Inc. | -168.24 Million USD | -21.848% |
| RenovoRx, Inc. | -11.39 Million USD | -1698.894% |
| Adicet Bio, Inc. | -152.03 Million USD | -34.836% |
| Prime Medicine, Inc. | -191.29 Million USD | -7.167% |
| Aditxt, Inc. | -26.06 Million USD | -686.581% |
| Adagene Inc. | -23.71 Million USD | -764.263% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2704.367% |
| Quantum-Si incorporated | -111.17 Million USD | -84.402% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -547.757% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1306.265% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 268.015% |
| SciSparc Ltd. | -5.77 Million USD | -3451.048% |
| Vericel Corporation | -6.46 Million USD | -3071.442% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2268.141% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -786.703% |
| Generation Bio Co. | -138.56 Million USD | -47.949% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -146.901% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -137.106% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | 14.973% |
| Invivyd, Inc. | -207.78 Million USD | 1.338% |
| Relay Therapeutics, Inc. | -373 Million USD | 45.04% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -2085.871% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1054.341% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1892.826% |
| 2seventy bio, Inc. | -216.7 Million USD | 5.4% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1047.679% |
| Clene Inc. | -40.54 Million USD | -405.678% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -751.413% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -274.119% |
| GeoVax Labs, Inc. | -26.74 Million USD | -666.565% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 41.438% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -458.102% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 1375.126% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -97.684% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -502.912% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -20.393% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 70.042% |
| Evaxion Biotech A/S | -22.19 Million USD | -823.557% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -148.843% |
| Verve Therapeutics, Inc. | -223.12 Million USD | 8.122% |
| Trevena, Inc. | -35.28 Million USD | -480.94% |
| Surrozen, Inc. | -45.78 Million USD | -347.798% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -156.429% |
| Cingulate Inc. | -22.75 Million USD | -800.744% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 2836.279% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -358.956% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -2389.719% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -99.889% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -179.374% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -230.254% |
| Clearmind Medicine Inc. | -8.74 Million USD | -2245.198% |
| Kronos Bio, Inc. | -121.83 Million USD | -68.269% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -169.046% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -6889.535% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -103.321% |
| Statera Biopharma, Inc. | -98.34 Million USD | -108.454% |
| ImmunityBio, Inc. | -362.25 Million USD | 43.409% |
| Korro Bio, Inc. | -84.53 Million USD | -142.508% |
| Kineta, Inc. | -15.72 Million USD | -1203.835% |
| BioVie Inc. | -32.17 Million USD | -537.056% |
| Codexis, Inc. | -68.06 Million USD | -201.168% |
| Celularity Inc. | -192.28 Million USD | -6.613% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | 7.909% |
| Celcuity Inc. | -66.23 Million USD | -209.529% |
| Virax Biolabs Group Limited | -6.49 Million USD | -3055.589% |
| Cibus, Inc. | -318.88 Million USD | 35.712% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -376.749% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -505.726% |
| IN8bio, Inc. | -30.33 Million USD | -575.749% |
| Kodiak Sciences Inc. | -277.32 Million USD | 26.078% |
| Annexon, Inc. | -143.72 Million USD | -42.637% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -65.603% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -217.115% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -774.433% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 42.046% |
| Eyenovia, Inc. | -25.4 Million USD | -706.89% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 728.07% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -3585.761% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -159.06% |
| Arcellx, Inc. | -89.88 Million USD | -128.084% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -351.427% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -49.411% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -558.98% |
| Moolec Science SA | -6.65 Million USD | -2980.974% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -235.31% |
| Geron Corporation | -193.94 Million USD | -5.702% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -373.96% |
| Royalty Pharma plc | 1.49 Billion USD | 113.739% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -24.878% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2097.737% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -836.31% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -19.914% |
| Humacyte, Inc. | -100.04 Million USD | -104.906% |
| Structure Therapeutics Inc. | -102.77 Million USD | -99.467% |
| 89bio, Inc. | -151.2 Million USD | -35.58% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -155.83% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -1309.917% |
| Genelux Corporation | -24.16 Million USD | -748.343% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -504.316% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -19.361% |
| Notable Labs, Ltd. | -14.65 Million USD | -1298.663% |
| Liquidia Corporation | -73.38 Million USD | -179.355% |
| Mustang Bio, Inc. | -50.72 Million USD | -304.136% |
| Immunovant, Inc. | -282.7 Million USD | 27.487% |
| Quantum-Si incorporated | -111.17 Million USD | -84.402% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -162.476% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -863.944% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -100.959% |
| Acasti Pharma Inc. | -11.31 Million USD | -1712.252% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -794.381% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -1182.917% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | 4.229% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -5487.298% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1190.457% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -603.097% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -395.365% |
| PepGen Inc. | -84.76 Million USD | -141.845% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -591.85% |
| United Therapeutics Corporation | 1.18 Billion USD | 117.301% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -795.323% |
| Solid Biosciences Inc. | -104.31 Million USD | -96.522% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -524.851% |
| Immuneering Corporation | -58.41 Million USD | -250.953% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -3927.357% |
| Silo Pharma, Inc. | -3.85 Million USD | -5217.004% |
| Belite Bio, Inc | -31.66 Million USD | -547.347% |
| XOMA Corporation | -41.84 Million USD | -389.873% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -203.617% |
| Bionomics Limited | -17.89 Billion USD | 98.854% |
| Apogee Therapeutics, Inc. | -93 Million USD | -120.425% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 674.557% |
| uniQure N.V. | -282.87 Million USD | 27.528% |
| Cassava Sciences, Inc. | -105.95 Million USD | -93.477% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2704.367% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -58.298% |
| Forte Biosciences, Inc. | -32.48 Million USD | -531.047% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -2367.301% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -597.404% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -3585.761% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1342.66% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -2206.244% |
| Altimmune, Inc. | -95.92 Million USD | -113.702% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -178.937% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 674.557% |
| Compugen Ltd. | -12.99 Million USD | -1477.909% |
| Peak Bio, Inc. | -1356.23 USD | -15115477.741% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -313.277% |
| Benitec Biopharma Inc. | -22.49 Million USD | -811.525% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 15.394% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -589.175% |
| Zura Bio Limited | -62.63 Million USD | -227.281% |
| PolyPid Ltd. | -22.86 Million USD | -796.497% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -1159.536% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -589.175% |
| Instil Bio, Inc. | -159.16 Million USD | -28.795% |
| argenx SE | -425.04 Million USD | 51.77% |
| Immunome, Inc. | -109.53 Million USD | -87.165% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -307.049% |
| Verona Pharma plc | -67.83 Million USD | -202.225% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -686.654% |
| Shattuck Labs, Inc. | -91.95 Million USD | -122.932% |
| CervoMed Inc. | -7.81 Million USD | -2523.893% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -180.402% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -1438.939% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -325.545% |
| Moolec Science SA | -6.65 Million USD | -2980.974% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -1146.331% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -51.599% |
| AnaptysBio, Inc. | -164.41 Million USD | -24.689% |
| Design Therapeutics, Inc. | -78.19 Million USD | -162.184% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -135.523% |
| NeurAxis, Inc. | -6.66 Million USD | -2976.032% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -406.19% |
| Lumos Pharma, Inc. | -36.61 Million USD | -459.901% |
| Achilles Therapeutics plc | -75.25 Million USD | -172.41% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -686.654% |
| 180 Life Sciences Corp. | -13.47 Million USD | -1421.068% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 4075.749% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -6889.535% |
| Nutriband Inc. | -4.87 Million USD | -4107.823% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -85.053% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -269.713% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -303.261% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -210.144% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -278.77% |
| Palisade Bio, Inc. | -13.07 Million USD | -1468.493% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -351.457% |
| Beam Therapeutics Inc. | -176.48 Million USD | -16.158% |
| Neurogene Inc. | -55.58 Million USD | -268.821% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -87.81% |
| AEON Biopharma, Inc. | -48.42 Million USD | -323.304% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -111.976% |
| Sesen Bio, Inc. | -25.9 Million USD | -691.239% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -145.426% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -1528.694% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 55.488% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -182.999% |
| Athira Pharma, Inc. | -125.46 Million USD | -63.392% |
| Vaccinex, Inc. | -22.88 Million USD | -795.792% |
| HCW Biologics Inc. | -25.71 Million USD | -697.141% |
| XOMA Corporation | -41.84 Million USD | -389.873% |
| Nektar Therapeutics | -137.42 Million USD | -49.174% |
| Arvinas, Inc. | -401.5 Million USD | 48.941% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -2318132.552% |
| Merus N.V. | -156.54 Million USD | -30.952% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -104.468% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -492.149% |
| Rezolute, Inc. | -70.42 Million USD | -191.101% |
| Clene Inc. | -40.54 Million USD | -405.678% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -1151.655% |
| BeyondSpring Inc. | -23.11 Million USD | -786.917% |
| Synlogic, Inc. | -55.16 Million USD | -271.643% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -1043.41% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1793.958% |
| Peak Bio, Inc. | -1356.23 USD | -15115477.741% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -406.14% |
| Krystal Biotech, Inc. | -109.72 Million USD | -86.829% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -58.254% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 40.235% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -4219.512% |
| MannKind Corporation | 8.67 Million USD | 2462.319% |
| Ikena Oncology, Inc. | -75.41 Million USD | -171.825% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -2025.034% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -204.926% |
| Gossamer Bio, Inc. | -183.75 Million USD | -11.56% |
| CohBar, Inc. | -12.38 Million USD | -1554.804% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -304.152% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -643.111% |
| Legend Biotech Corporation | -439.48 Million USD | 53.354% |
| Mural Oncology plc | -194.63 Million USD | -5.325% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -205.321% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1169.734% |
| Disc Medicine, Inc. | -91.12 Million USD | -124.968% |
| Champions Oncology, Inc. | -7.35 Million USD | -2686.868% |
| REGENXBIO Inc. | -268.12 Million USD | 23.543% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1812.656% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -267.677% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -426.177% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -79.265% |
| Vaxart, Inc. | -83.34 Million USD | -145.962% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -2306.125% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -379.043% |
| Cellectis S.A. | -106.62 Million USD | -92.263% |
| Longeveron Inc. | -21.02 Million USD | -874.854% |
| Repare Therapeutics Inc. | -116.22 Million USD | -76.385% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 23.456% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -171.005% |
| Revolution Medicines, Inc. | -487.18 Million USD | 57.921% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -2981.81% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -366.401% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -174.838% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -194.395% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -1761.793% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 104.759% |
| Denali Therapeutics Inc. | -196.69 Million USD | -4.221% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -2268.141% |
| Veru Inc. | -93.78 Million USD | -118.594% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -778.743% |
| Cingulate Inc. | -22.75 Million USD | -800.744% |
| Passage Bio, Inc. | -108.38 Million USD | -89.135% |
| Context Therapeutics Inc. | -25.07 Million USD | -717.633% |
| Exicure, Inc. | -14.99 Million USD | -1267.045% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 0.515% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -404.956% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -2009.739% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -11.198% |
| Nuvalent, Inc. | -149.49 Million USD | -37.132% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -2395.001% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -131.038% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -886.82% |
| OmniAb, Inc. | -69.41 Million USD | -195.311% |
| Anew Medical, Inc. | -1.3 Million USD | -15659.202% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -1505.215% |
| Lipocine Inc. | -17.93 Million USD | -1043.285% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -199.216% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -169.201% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -438.412% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -418.638% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -815.842% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 64.646% |
| Ocugen, Inc. | -65.53 Million USD | -212.832% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -118.399% |
| Q32 Bio Inc. | -92.1 Million USD | -122.581% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -856.211% |
| Alumis Inc. Common Stock | -158.17 Million USD | -29.605% |
| Equillium, Inc. | -14.52 Million USD | -1311.665% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -228.497% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -2493.862% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -986.673% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -336.63% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -89.001% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -1612.629% |
| Dominari Holdings Inc. | -21.79 Million USD | -840.549% |
| Edesa Biotech, Inc. | -9.22 Million USD | -2122.784% |
| vTv Therapeutics Inc. | -25.5 Million USD | -703.866% |
| Bio-Techne Corporation | 206.68 Million USD | 199.185% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 47.635% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 206.755% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -54.979% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -433.985% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -35.672% |
| Nkarta, Inc. | -131.65 Million USD | -55.717% |
| BioCardia, Inc. | -11.64 Million USD | -1660.581% |
| Iterum Therapeutics plc | -47.46 Million USD | -331.874% |